Video Experimental Relacionado
Updated: Sep 24, 2026
08:15
Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice
Published on: September 17, 2015
Una comparación de verapamil y propranolol para el tratamiento inicial de la hipertensión. Diferencias raciales en la
JAMA
|October 24, 1986
Resumen
El verapamil reduce efectivamente la presión arterial (PA) tanto en pacientes negros como en blancos con hipertensión, superando el rendimiento del propranolol. Este estudio destaca el verapamil como una monoterapia segura y efectiva para el manejo de la hipertensión esencial.
Área de la Ciencia:
- Cardiología Cardiología.
- Farmacología Farmacología.
- Investigación de la Hipertensión Investigación de la Hipertensión
Sus antecedentes:
- La hipertensión esencial es una condición generalizada que requiere una monoterapia efectiva.
- Comparar la eficacia y la seguridad de diferentes agentes antihipertensivos es crucial para una atención óptima del paciente.
- El verapamil y el clorhidrato de propranolol son medicamentos establecidos para el manejo de la hipertensión.
Objetivo del estudio:
- Para comparar la eficacia del verapamil frente al clorhidrato de propranolol como monoterapia para la hipertensión esencial.
- Para evaluar la efectividad del tratamiento en diferentes grupos raciales (pacientes blancos y negros).
- Evaluar los perfiles de seguridad y los efectos secundarios tanto del verapamil como del propranolol.
Principales métodos:
- Un estudio comparativo en el que participaron pacientes con hipertensión esencial.
- Monoterapia ya sea con verapamil o con clorhidrato de propranolol.
- Monitoreo de la presión arterial (BP), la frecuencia cardíaca, el intervalo PR y los eventos adversos.
Principales resultados:
- El verapamil demostró una reducción superior de la presión arterial en comparación con el propranolol en pacientes blancos y negros.
- El verapamil fue igualmente efectivo en pacientes blancos y negros, mientras que el propranolol fue más efectivo en pacientes blancos.
- El verapamil mostró una menor incidencia de aumento de la presión arterial sistólica y menos efectos adversos como fatiga y mareos en comparación con el propranolol.
Conclusiones:
- La monoterapia con verapamil es un tratamiento seguro y eficaz para lograr el control de la presión arterial en pacientes con hipertensión esencial.
- El verapamil ofrece un efecto reductor de la presión arterial más consistente en diferentes grupos raciales en comparación con el propranolol.
- Verapamil presenta un perfil de seguridad favorable con efectos secundarios manejables para el manejo de la hipertensión.
Videos de Conceptos Relacionados
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...